Skip to main content
. 2020 Nov 29;48(11):0300060520967829. doi: 10.1177/0300060520967829

Figure 1.

Figure 1.

Serum and urinary NGAL and miR-652-3p expression levels in patients with acute decompensated heart failure. (a) and (b). Serum and urinary NGAL levels in patients with AKI and those without AKI. (c) and (d) Serum and urinary miR-652-3p mRNA expression in patients with AKI and those without AKI. *P < 0.05.

AKI, acute kidney injury; NGAL, neutrophil gelatinase-associated lipocalin.